Cohort Study | Systemic lupus erythematosus low disease activity and mortality risk.

Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study – The Lancet Rheumatology (link to abstract – $ for full-text)

Commentary on Twitter

NEW RESEARCH—Lupus low disease activity state (#LLDAS) significantly reduced the risk of mortality in patients with #SLE; remission did not further reduce the risk of mortality unless lower glucocorticoid thresholds were used https://t.co/xYqzQME3li #LupusAwarenessMonth pic.twitter.com/gtLTKn92Go

— The Lancet Rheumatology (@TheLancetRheum) October 24, 2022